Xenon Pharmaceuticals (XENE) Other Gross PP&E Adjustments: 2013-2025
Historic Other Gross PP&E Adjustments for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to -$9.5 million.
- Xenon Pharmaceuticals' Other Gross PP&E Adjustments rose 3.50% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.8 million, marking a year-over-year increase of 31.43%. This contributed to the annual value of $2.9 million for FY2024, which is 174.86% up from last year.
- Latest data reveals that Xenon Pharmaceuticals reported Other Gross PP&E Adjustments of -$9.5 million as of Q3 2025, which was down 18.08% from -$8.0 million recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $2.9 million during Q4 2024, and its lowest value of -$10.9 million during Q1 2023.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$9.8 million (2024), whereas its average is -$8.2 million.
- Per our database at Business Quant, Xenon Pharmaceuticals' Other Gross PP&E Adjustments slumped by 1,271.89% in 2022 and then surged by 174.86% in 2024.
- Xenon Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$217,000 in 2021, then crashed by 1,271.89% to -$3.0 million in 2022, then tumbled by 31.47% to -$3.9 million in 2023, then skyrocketed by 174.86% to $2.9 million in 2024, then climbed by 3.50% to -$9.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$9.5 million for Q3 2025, versus -$8.0 million for Q2 2025 and -$9.2 million for Q1 2025.